2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosisMike P. Wattjes, Olga Ciccarelli, Daniel S. Reich et al.|The Lancet Neurology|2021Cited by 646
Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple SclerosisAnthony Traboulsee, David K.B. Li|American Journal of Neuroradiology|2015Cited by 333
Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines.Jack H. Simon, Jerry S. Wolinsky, David K.B. Li et al.|PubMed|2006Cited by 287
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 studyKrzysztof Selmaj, Erik Wallström, David K.B. Li et al.|The Lancet Neurology|2013Cited by 233
Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple SclerosisLudwig Kappos, Krzysztof Selmaj, David K.B. Li et al.|JAMA Neurology|2016Cited by 103